高级检索
当前位置: 首页 > 详情页

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel

文献详情

资源类型:
机构: [1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [2]Guangdong Acad Med Sci, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [3]Tianjin Med Univ Canc Inst & Hosp, Dept Lung Canc, Tianjin, Peoples R China; [4]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Natl GCP Ctr Anticanc Agents, Beijing, Peoples R China; [5]Peking Union Med Coll, Beijing, Peoples R China; [6]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China; [7]Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China; [8]China Food & Drug Adm, Ctr Drug Evaluat, Beijing, Peoples R China; [9]West China Hosp, Lung Canc Ctr, Chengdu, Sichuan, Peoples R China; [10]Jilin Prov Canc Hosp, Dept Thorac Oncol, Changchun, Jilin, Peoples R China; [11]307 Hosp Acad Mil Med Sci, Dept Pulm Oncol, Beijing, Peoples R China; [12]Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China; [13]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China; [14]Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [15]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai, Peoples R China; [16]Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China; [17]Peking Univ, People Hosp, Dept Thorac Surg, Beijing, Peoples R China; [18]Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [19]Burning Rock Biotech, Guangzhou, Peoples R China; [20]Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China; [21]Nanjing Med Univ, Coll Basic Med, Nanjing, Jiangsu, Peoples R China; [22]Geno Biotech Co Ltd, Shanghai, Peoples R China; [23]Amoy Diagnost, R&D Dept, Xiamen, Peoples R China; [24]3D Med, Shanghai, Peoples R China; [25]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Hubei, Peoples R China; [26]Peking Univ, Canc Hosp & Inst, Dept Thorac Surg, Beijing, Peoples R China; [27]Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China; [28]Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [29]Jiangsu Canc Hosp, Dept Chemotherapy, Nanjing, Jiangsu, Peoples R China; [30]Jiangsu Canc Hosp, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [31]Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Chest Surg, Guangzhou, Guangdong, Peoples R China; [32]Wuhan Univ, Canc Ctr Renmin Hosp, Wuhan, Hubei, Peoples R China; [33]Gen Hosp Guangzhou Command, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [34]Hubei Canc Hosp, Dept Med Oncol, Wuhan, Hubei, Peoples R China; [35]Huazhong Univ Sci & Technol, Tongji Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China; [36]301 Gen Hosp, Dept Internal Oncol, Beijing, Peoples R China; [37]Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [38]Harbin Med Univ, Affiliated Tumor Hosp, Dept Med Oncol, Harbin, Heilongjiang, Peoples R China; [39]Zhejiang Canc Hosp, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China; [40]Tangdu Hosp, Dept Med Oncol, Xian, Shaanxi, Peoples R China; [41]Peking Univ, Canc Hosp & Inst, Dept Radiat Oncol, Beijing, Peoples R China; [42]Jilin Univ, Hosp 1, Canc Ctr, Changchun, Peoples R China; [43]Zhejiang Univ, Affiliated Hosp 1, Dept Thorac Oncol, Hangzhou, Zhejiang, Peoples R China; [44]China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [45]West China Hosp, Dept Thorac Canc, Chengdu, Sichuan, Peoples R China; [46]Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China; [47]Peking Univ, Canc Hosp & Inst, Dept Thorac Surg 2, Beijing, Peoples R China; [48]Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China; [49]Dalian Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Dalian, Peoples R China
出处:
ISSN:

摘要:
The diagnosis and treatment of lung cancer have evolved into the era of precision medicine. Liquid biopsy, a minimally invasive approach, has emerged as a promising practice in genetic profiling and monitoring of lung cancer. Translating liquid biopsy from bench to bedside has encountered various challenges, including technique selection, protocol standardisation, data analysis and cost management. Regarding these challenges, the 2016 Chinese Lung Cancer Summit expert panel organised a trilateral forum involving oncologists, clinicians, clinical researchers, and industrial expertise on the 13th Chinese Lung Cancer Summit to formally discuss these controversies. Six consensuses were reached to guide the use of liquid biopsy and perform precision medicine in both clinic and research.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
第一作者:
第一作者机构: [1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [2]Guangdong Acad Med Sci, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [2]Guangdong Acad Med Sci, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号